Status: Not yet recruiting
Role of Dexmedetomidine as Synergistic Agent
The aim of this clinical trial is to contribute valuable insights into the role of Dexmedetomidine as a synergistic agent in prolonging subarachnoid block duration, with the overarching goal of enhancing perioperative care and surgical success rates.
Participants needed: 166
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Lady Reading Hospital, PakistanUpdated: Oct 28, 2024Locations: 1
Eligibility criteria
Patients of either gender aged between 18 and 65 years. [+2]
Patients with contraindications to subarachnoid anesthesia, including severe coa... [+6]